This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Knechtli CJ, Goulden NJ, Hancock JP et al. Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia. Blood 1998; 92: 4072–4079.
Bader P, Hancock J, Kreyenberg H et al. Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL. Leukemia 2002; 16: 1668–1672.
van der Velden VH, Joosten SA, Willemse MJ et al. Real-time quantitative PCR for detection of minimal residual disease before allogeneic stem cell transplantation predicts outcome in children with acute lymphoblastic leukemia. Leukemia 2001; 15: 1485–1487.
Szczepanski T, van der Velden VH, van Dongen JJ . Real-time quantitative (RQ)-PCR for the detection of minimal residual disease in childhood acute lymphoblastic leukemia. Haematologica 2002; 87: 183–191.
Verhagen OJ, Willemse MJ, Breunis WB et al. Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia. Leukemia 2000; 14: 1426–1435.
van der Velden VH, Wijkhuijs JM, Jacobs DC et al. T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysis. Leukemia 2002; 16: 1372–1380.
van der Velden VH, Willemse MJ, van der Schoot CE et al. Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR. Leukemia 2002; 16: 928–936.
Pongers-Willemse MJ, Seriu T, Stolz F et al. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemia. Leukemia 1999; 13: 110–118.
van Dongen JJ, Seriu T, Panzer-Grumayer ER et al. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet 1998; 352: 1731–1738.
Uzunel M, Mattsson J, Jaksch M et al. The significance of graft-versus-host disease and pretransplantation minimal residual disease status to outcome after allogeneic stem cell transplantation in patients with acute lymphoblastic leukemia. Blood 2001; 98: 1982–1984.
Bader P, Klingebiel T, Schaudt A et al. Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center experience of 12 children. Leukemia 1999; 13: 2079–2086.
Acknowledgements
We thank all colleagues involved in sample collection and patient care in participating centres. We also thank Dr Vera Lanska for the statistical analysis and Annemarie Wijkhuijs and Marjon van Dijk for technical assistance. This work was supported by grants: 6512-3 IGA, 301/P041 GACR, Dutch Cancer Society/Koningin Wilhelmina Fonds (Grants SNWLK 97-1567 and SNWLK 2000-2268) (VHJvdV and JJMvD) and BMBF: IZKF Projekt IIA (PB).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Krejci, O., van der Velden, V., Bader, P. et al. Level of minimal residual disease prior to haematopoietic stem cell transplantation predicts prognosis in paediatric patients with acute lymphoblastic leukaemia: a report of the Pre-BMT MRD Study Group. Bone Marrow Transplant 32, 849–851 (2003). https://doi.org/10.1038/sj.bmt.1704241
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704241
This article is cited by
-
Flow Cytometric Minimal Residual Disease Analysis in Acute Leukemia: Current Status
Indian Journal of Hematology and Blood Transfusion (2020)
-
Hematopoietic Stem Cell Transplantation for Childhood Acute Lymphoblastic Leukemia and the Role of MRD: A Single Centre Experience from India
Indian Journal of Hematology and Blood Transfusion (2018)
-
Next-generation sequencing indicates false-positive MRD results and better predicts prognosis after SCT in patients with childhood ALL
Bone Marrow Transplantation (2017)
-
Therapy of pediatric ALL relapsing after allogeneic transplant: how to make progress with limited patient numbers?
Bone Marrow Transplantation (2017)
-
Is Next-Generation Sequencing the way to go for Residual Disease Monitoring in Acute Lymphoblastic Leukemia?
Molecular Diagnosis & Therapy (2017)